Key result
Strict fat restriction plus targeted pharmacotherapy lowers severe hypertriglyceridemia in pediatric familial chylomicronemia syndrome.
Why the study?
Monogenic familial chylomicronemia syndrome has phenotypic variation that often leads to diagnostic delays.
Case Report (n=2)
This case series highlights the diagnostic challenges of pediatric familial chylomicronemia syndrome and demonstrates that early molecular confirmation is crucial for guiding individualized dietary and pharmacological management.
Supports individualized management in rare pediatric monogenic FCS; hypothesis-generating and requires prospective validation before practice change.
Monogenic familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder caused by disrupted intravascular lipoprotein lipase (LPL) pathways. Phenotypic variation often leads to diagnostic delays. We contrast two unique pediatric presentations of FCS, highlighting distinct pathophysiology. Case 1 describes a 21-month-old girl with eruptive xanthomas, which was initially misdiagnosed as an infectious rash, later revealed to be secondary to severe hypertriglyceridemia of 100.6 mmol/L (reference range < 0.8 mmol/L). Molecular testing confirmed a genetic mutation in the GPIHBP1 gene. Case 2 describes a 2-day-old neonate with incidental finding of lipemia during jaundice evaluation, subsequently revealing a fasting triglyceride level of 8.5 mmol/L. Genetic analysis identified compound heterozygous mutations in the LPL gene. Case 1 required intensive insulin therapy, strict dietary fat restriction and adjunctive gemfibrozil. Case 2 was managed via dietary restriction and medium-chain triglyceride formula supplementation. This two-case series illustrates the diagnostic challenges of FCS in pediatric practice and the contribution of molecular confirmation to establishing the underlying aetiology and informing counselling and long-term management.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) conducted a case report in Monogenic Familial Chylomicronemia Syndrome (n=2). Dietary fat restriction and medical management was evaluated on Serum triglyceride levels. Individualized management with strict dietary fat restriction and targeted pharmacotherapy successfully reduced severe hypertriglyceridemia in two pediatric patients with monogenic familial chylomicronemia syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: